Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001193125-25-313147

PRESIDENT & CEO sold 25,205 shares at an average $45.33 ($1,142,513)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MORTIMER IAN · PRESIDENT & CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-05 Sale : show line 1 in the form 10b5-1 −14,375 $45.03 $647,306 16,830 D
2025-12-08 Sale : show line 2 in the form 10b5-1 −8,820 $45.59 $402,104 8,010 D
2025-12-08 Sale : show line 3 in the form 10b5-1 −2,010 $46.32 $93,103 6,000 D
Open-market sales · 25,205 sh · avg $45.33 · $1,142,513
Loading xslF345X05/ownership.xml…